Monosialoganglioside GM-1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Monosialoganglioside GM-1, covering 2017-03-01 to 2017-03-01. Get the full timeline:
Most recent: Clinical Trial Update: Monosialoganglioside Ganglioside in Cerebral Radiation Necrosis [Phase 2]